These findings suggest that propofol has a tumor-suppressive role in the regulation of cell viability, migration, and invasion of bladder cancer cells by targeting the miR-10b/HOXD10 signaling pathway [65]. The gene discussed is HOXD10; the disease is urinary bladder cancer.